Mevastatin Market to Reach USD 240 Million by 2032 Driven by Rising Cardiovascular Disease Prevalence
The global market for Mevastatin, a cholesterol-lowering medication and a key member of the statin family, is projected to experience steady growth over the next decade. According to a detailed report by Wise Guy Reports, the market is expected to expand from an estimated $160 million in 2024 to $240 million by 2032, registering a compound annual … Read more